Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: An emerging autoinflammatory paraneoplastic disorder
- 26 July 2026
- journal article
- Published by Elsevier in Clinics in Dermatology
- Vol. 44 (5) , 760-769
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Skin Manifestations of VEXAS Syndrome and Associated GenotypesJAMA Dermatology, 2024
- VEXAS‐Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us CohortArthritis & Rheumatology, 2024
- VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and managementAmerican Journal of Hematology, 2023
- Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical PopulationJAMA, 2023
- Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic reviewRheumatology International, 2023
- Ear, Nose, Throat, and Bronchial Involvements in VEXAS SyndromeJAMA Otolaryngology–Head & Neck Surgery, 2022
- VEXAS syndrome in dermatologyArchives of Dermatological Research, 2022
- VEXAS Syndrome: A Case Series From a Single‐Center Cohort of Italian Patients With VasculitisArthritis & Rheumatology, 2021
- UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS SyndromeJAMA Dermatology, 2021
- Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXASArthritis & Rheumatology, 2021